Top Page
InteliCare Holdings Limited
(Sydney:ICR)
InteliCare Holdings Limited (ICR) vs. iShares MSCI Australia ETF (EWA)
InteliCare Holdings Limited Business Overview & Revenue Model
InteliCare Holdings Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 956.74K | 956.74K | 280.29K | 404.35K | 429.85K | 363.12K |
| Gross Profit | -1.09M | -1.09M | -1.79M | -2.69M | -2.75M | -1.99M |
| EBITDA | -2.16M | -2.16M | -3.02M | -2.89M | -3.78M | -4.24M |
| Net Income | -2.24M | -2.24M | -2.26M | -3.00M | -3.93M | -4.36M |
Balance Sheet | ||||||
| Total Assets | 1.02M | 1.02M | 1.52M | 2.48M | 2.88M | 3.43M |
| Cash, Cash Equivalents and Short-Term Investments | 410.53K | 410.53K | 834.20K | 1.94M | 2.27M | 2.67M |
| Total Debt | 716.62K | 716.62K | 612.39K | 726.57K | 18.25K | 85.16K |
| Total Liabilities | 1.86M | 1.86M | 1.69M | 1.53M | 1.34M | 842.64K |
| Stockholders Equity | -833.17K | -833.17K | -168.32K | 949.11K | 1.54M | 2.59M |
Cash Flow | ||||||
| Free Cash Flow | -1.67M | -1.67M | -1.66M | -3.11M | -3.14M | -3.86M |
| Operating Cash Flow | -1.67M | -1.67M | -1.66M | -3.10M | -3.10M | -3.79M |
| Investing Cash Flow | -7.09K | -7.09K | 0.00 | -14.35K | -32.92K | -74.79K |
| Financing Cash Flow | 1.25M | 1.25M | 555.65K | 2.78M | 2.73M | 2.34M |
InteliCare Holdings Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | AU$45.15M | -8.00 | -81.30% | ― | -36.68% | 79.41% | |
44 Neutral | AU$14.93M | -4.58 | ― | ― | 241.34% | 44.19% | |
44 Neutral | AU$10.57M | -1.03 | ― | ― | -40.05% | -49.57% | |
43 Neutral | AU$2.38M | -2.50 | -29.86% | ― | ― | 78.95% | |
43 Neutral | AU$81.63M | -11.67 | ― | ― | ― | ― | |
41 Neutral | AU$4.99M | -4.83 | ― | ― | -9.90% | 34.07% |
InteliCare Holdings Limited Corporate Events
InteliCare Holdings Limited has notified the market that it has issued performance rights and confirms it remains in full compliance with its financial reporting and continuous disclosure obligations under the Corporations Act. The company states there is no undisclosed price-sensitive information that investors or their advisers would reasonably require to assess its financial position, prospects, or the rights attached to its fully paid ordinary shares, reinforcing transparency around the new performance rights issuance for shareholders and the broader market.
The most recent analyst rating on (AU:ICR) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on InteliCare Holdings Limited stock, see the AU:ICR Stock Forecast page.
InteliCare Holdings Limited has announced a proposed issue of up to 4.5 million performance rights (ASX code: ICRAP). The issue, structured as a placement or other type of securities issue and scheduled for 9 January 2026, signals the company’s intention to use equity-based instruments, likely as part of its capital management or incentive arrangements, with potential dilution implications for existing shareholders once the rights vest and convert into quoted securities.
The most recent analyst rating on (AU:ICR) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on InteliCare Holdings Limited stock, see the AU:ICR Stock Forecast page.
InteliCare Holdings Limited announced a change in the director’s interest, with Neale Fong acquiring an additional 4,500,000 performance rights, increasing his total to 18,500,000. This change, approved by shareholders at the AGM, indicates a strengthened commitment from the director, potentially impacting the company’s strategic direction and signaling confidence in its future growth.
InteliCare Holdings Limited announced a proposed issue of 15 million performance rights as part of a new securities placement. This move is likely aimed at strengthening the company’s financial position and supporting its strategic initiatives, potentially impacting its market presence and offering benefits to stakeholders.
InteliCare Holdings Limited has issued fully paid ordinary shares and has complied with relevant provisions of the Corporations Act, including continuous disclosure requirements. The company confirms that there is no undisclosed information that investors would need for an informed assessment of the company’s financial position or the rights attached to the shares.
InteliCare Holdings Limited has announced the quotation of 11,498,798 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 8, 2025. This move is part of previously announced transactions and reflects the company’s ongoing efforts to strengthen its financial position and enhance market presence, potentially impacting its operational capabilities and stakeholder interests.
InteliCare Holdings Limited announced the results of its Annual General Meeting held on 19 November 2025, where all resolutions were passed by a poll. Key resolutions included the re-election of a director, approval of a 10% placement facility, ratification of placement shares, and re-approval of the Employee Securities Incentive Plan. These outcomes reflect shareholder support for the company’s strategic initiatives, potentially strengthening its market position and operational capacity.
InteliCare Holdings Limited has issued a notice under section 708A(5) of the Corporations Act regarding the issuance of Performance Rights, which can be converted into fully paid ordinary shares. The company confirms compliance with relevant provisions of the Corporations Act and states that there is no undisclosed information that would affect investors’ ability to make informed assessments of the company’s financial position or the rights associated with its shares.
InteliCare Holdings Limited has announced a proposed issue of 12 million performance rights as part of a placement or other type of issue. This move is expected to impact the company’s operations by potentially increasing its capital base, which could be used for further development and expansion, thus strengthening its position in the smart care technology industry.
InteliCare Holdings Ltd announced significant progress in its operations for the September 2025 quarter, highlighted by the successful completion of a pilot project with mecwacare at the Trescowthick Centre. This deployment, the largest to date, integrated seamlessly with existing systems and introduced new platform capabilities, paving the way for a potential enterprise-wide rollout across mecwacare’s 23 facilities. Additionally, InteliCare completed key system integrations with Hardi Aged Care and extended its engagement with the Western Australian Country Health Service (WACHS), while also raising $2 million in capital to support these initiatives. These developments underscore InteliCare’s strategic positioning in the aged care sector and its potential for expansion, providing a strong foundation for future growth.
InteliCare Holdings Limited reported a net cash outflow from operating activities of $834,000 for the quarter ending September 30, 2025. Despite this, the company secured $2,176,000 from financing activities, primarily through equity securities and borrowings, resulting in a net increase in cash and cash equivalents of $412,000. This financial maneuvering indicates a strategic effort to bolster liquidity and sustain operations amid ongoing expenditures, reflecting the company’s focus on maintaining its market position and operational capabilities.
InteliCare Holdings Limited has announced the conversion of options into fully paid ordinary shares, in compliance with relevant sections of the Corporations Act. The company confirms that all necessary disclosures have been made, ensuring transparency for investors and their advisors regarding the company’s financial position and the rights attached to the shares.
InteliCare Holdings Limited has announced the quotation of 666,667 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code ICR. This move is part of the company’s strategy to enhance its financial flexibility and potentially strengthen its market position by increasing the liquidity of its shares.
InteliCare Holdings Limited has announced the details for its 2025 Annual General Meeting, scheduled for November 19, 2025, in Leederville, Western Australia. The company is shifting towards electronic distribution of meeting materials, encouraging shareholders to access documents online and vote via proxy forms. This move reflects a broader industry trend towards digitalization, potentially improving shareholder engagement and operational efficiency.
InteliCare Holdings Limited has announced its 2025 Annual General Meeting, scheduled for November 19, 2025, at their office in Leederville, Western Australia. The meeting will cover the company’s annual report, a non-binding resolution on the remuneration report, and the re-election of director Greg Leach. Shareholders are encouraged to participate and vote, with eligibility determined as of November 17, 2025. The meeting’s outcomes could influence the company’s governance and strategic direction.
InteliCare Holdings Limited has released its financial report for the year ending June 30, 2025. The report highlights the company’s continued efforts in strengthening its market position through strategic initiatives and technological advancements. This announcement is likely to impact the company’s operations positively by reinforcing its commitment to innovation and potentially attracting more stakeholders interested in the tech-driven care solutions market.
InteliCare Holdings Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is now available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, indicating full compliance with the guidelines. This announcement underscores InteliCare’s commitment to maintaining high standards of corporate governance, which is crucial for investor confidence and the company’s reputation in the competitive technology and healthcare sectors.
InteliCare Holdings Limited has adopted the 4th edition of the ASX Corporate Governance Council’s Principles and Recommendations to enhance its corporate governance framework. The company emphasizes the importance of leadership, strategic objectives, risk management, and ethical standards in its operations. As InteliCare’s activities expand, the board will review its composition and governance policies to ensure they remain effective and aligned with the company’s growth. This commitment to robust governance practices is aimed at maintaining transparency and accountability, which are crucial for stakeholder trust and the company’s long-term success.